Finding a lung cancer clinical trial that matches your situation
A useful lung cancer clinical-trial search starts with the exact diagnosis, stage, molecular results and previous treatments. Those details determine which studies are worth contacting. A registry listing is a starting point; the study team confirms whether a site is recruiting and whether you meet its criteria. Ask how the experimental treatment compares with your other options and whether screening fits safely into your current care.
On this page
Write a short clinical profile before searching
Record the cancer type, current stage, molecular alteration and date of the most recent scan. Add every prior systemic treatment, why it ended and whether you have active brain metastases. Current symptoms and general activity level are also relevant.
Keep the original reports behind that short summary. A phrase such as EGFR-positive after treatment is often too broad for trial matching. The exact variant and the specific drug that failed can determine which study cohort is relevant.
Sources and references: [1]
Search by the treatment question
Use combinations of disease, alteration and treatment history in recognized trial registries or cancer-center listings. A newly diagnosed stage III patient and someone with metastatic disease after several inhibitors need different searches. Trial identifiers help you distinguish studies with similar names.
Save the full registry record and the date checked. Note the phase, intervention, comparison group and participating sites. Rather than collecting a long list of interesting drugs, make a shorter list of studies whose eligibility appears close enough to justify an inquiry.
Sources and references: [1]
Read the criteria that commonly exclude a match
Studies may specify previous drugs, laboratory values, organ function, performance status or a particular molecular test. Brain metastases may be allowed only under defined conditions. Recent radiation or another treatment can also affect the screening timeline.
Ask the study team which criteria can be assessed from your records and which require new tests. A preliminary match is useful for planning, while formal screening confirms eligibility. Be accurate about side effects and prior treatments so the trial team can assess the risks properly.
Sources and references: [1]
Understand what the study is trying to learn
An early-phase study often focuses on dose, safety and preliminary activity. A later-phase trial may compare a new strategy with an existing treatment. Randomization can mean that the study treatment is not chosen by the patient or doctor.
Ask which treatment groups exist, what each contains and how assignment works. Also discuss what happens if the cancer progresses or side effects make continuation unsuitable. The informed-consent discussion should help you weigh the study against the standard options still available to you.
Fit screening into the cancer's timeline
Some trials require a period after the previous medicine, additional biopsy or central confirmation of a biomarker. These steps can take time. The current oncologist should assess whether the cancer is stable enough for that process or whether treatment needs to continue sooner.
Ask for the expected sequence from first contact to screening and, if eligible, treatment. Confirm which existing records the study can accept. Keep a backup plan with your oncologist in case a cohort is full, screening fails or the disease changes during the process.
Sources and references: [1]
Check the visits, costs and emergency support
A study may require more frequent scans, blood tests or visits than routine treatment. Ask which procedures are research-related, which costs are covered and which expenses remain yours. Travel and accommodation can be substantial even when an investigational medicine is supplied.
For an overseas study, confirm language support, consent arrangements and how urgent problems would be managed between visits. Also ask whether follow-up can ever be shared with a local clinician. These details help you judge whether participation is sustainable for you and your caregiver.
Sources and references: [2]
Send the study team a question it can answer
An effective inquiry names the trial identifier, diagnosis, mutation and prior-treatment sequence, then asks whether the site is screening patients with that profile. Request the required documents and the next step if the initial assessment is favorable.
The team may need a new scan or a specific test before giving a fuller answer. Keep correspondence and dates together, especially if several hospitals are being considered. Share any proposed change in treatment with your current oncologist before it affects eligibility or symptom control.
Sources and references: [1]
How EastMedGo can support a Shanghai trial inquiry
If a relevant study lists a Shanghai site, EastMedGo can help organize the records and the administrative inquiry. Send the trial identifier with the clinical summary rather than only the drug name. Our lung cancer resources can provide background for the hospital discussion.
The study team decides recruitment and eligibility. We can help clarify contact steps, appointment requirements and agreed coordination services. Before traveling, obtain the site's instructions about screening, expected visits and what happens if the study is not suitable after assessment.
Common questions
Are trials only for patients who have exhausted every treatment?
No. Trials exist at many stages, including initial treatment and treatment around surgery. Eligibility depends on the study question. It can be useful to ask about research options before the next treatment decision is urgent.
Sources and references: [2]
Does a recruiting registry status mean a place is available now?
The site team should confirm the relevant cohort and current screening arrangements. Registry information can lag behind local changes. Contact the actual participating site with your clinical profile and trial identifier.
Sources and references: [1]
Will all care be free in a clinical trial?
Costs vary. The study may cover an investigational treatment or certain research procedures while routine care, travel and accommodation follow different arrangements. Ask for a written explanation from the study site before committing.
Sources and references: [2]
Sources and references
Prepared with AI assistance by EastMedGo for patients comparing treatment and care options.